Transport Media Market Report 2025

The transport media market size has grown strongly in recent years. It will grow from $3.16 billion in 2024 to $3.33 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to urbanization trends, consumer mobility, innovative ad formats, regulatory support, targeted local advertising.

The transport media market size is expected to see strong growth in the next few years. It will grow to $4.27 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to data-driven advertising, smart city initiatives, rise of electric and autonomous vehicles, augmented reality (ar) integration, environmental sustainability. Major trends in the forecast period include integration with mobile technology, technological integration, digital transformation in transportation, sustainable packaging solutions, customization and personalization.

The rising prevalence of infectious diseases is expected to drive the growth of the transport media market. Infectious diseases are conditions that can be transmitted from one individual to another through contaminated food and beverages or via pathogens such as viruses, bacteria, fungi, and parasites. Molecular transport media facilitate safer sample handling and transportation, significantly reducing the risk of infection from infectious diseases. For instance, in February 2024, a report published by the UK Health Security Agency, a UK-based government organization, indicated that tuberculosis (TB) cases in England rose by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the increasing prevalence of infectious diseases is propelling the growth of the transport media market.

The growth trajectory of the pharmaceutical industry is expected to contribute significantly to the expansion of the transport media market. As a complex and multifaceted sector focused on the discovery, development, production, and marketing of pharmaceutical drugs, the pharmaceutical industry relies heavily on transport media to ensure the viability and integrity of biological samples during transportation and storage. With the ongoing growth and development of new drugs and therapies within the pharmaceutical industry, there is an increasing demand for reliable and efficient transport media. For instance, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA) reveals that North America accounted for 49.1 percent of global pharmaceutical sales, surpassing Europe's 23.4 percent in 2021. Moreover, the pharmaceutical industry invested over $43.15 million (€39,600 million) in research and development in Europe in 2020. Consequently, the expanding pharmaceutical industry, particularly in emerging markets, is a driving force propelling the transport media market forward.

Major companies operating in the transport media market are focused on developing innovative products, such as biosample collection kits, to ensure the safe and efficient transport of biological samples. A biosample collection kit is a set of tools and materials used for the safe collection, preservation, and transport of biological samples such as blood, saliva, tissue, or other bodily fluids. It is often paired with transport media to maintain the viability of collected biological samples, ensuring that they remain stable and uncontaminated during transport to diagnostic labs or research facilities for accurate analysis. For instance, in February 2022, Azooka Labs, an India-based biotechnology company, launched mWRAPR. It is the first indigenous biosample collection kit of India. This biological transport and storage medium is designed for genomic sequencing labs and biobanks, preserving genetic content in various samples like saliva, blood, and tissues.

Major players in the transport media market are actively pursuing technological innovations, such as viral inactivation medium, to secure a competitive advantage. The viral inactivation medium is a liquid solution crafted for the safe and effective collection and transportation of viral samples. It serves the critical function of inactivating viruses within the sample, preventing replication and mitigating the risk to laboratory personnel or the public. Thermo Fisher Scientific, a US-based provider of laboratory testing solutions, exemplifies this innovation by launching InhibiSURE in March 2022. This liquid medium is specifically designed for the collection, transportation, and inactivation of SARS-CoV-2 and other RNA-enveloped viruses. It utilizes a non-hazardous formulation to rapidly inactivate the virus while stabilizing viral RNA at ambient temperature.

In May 2023, VH Bio, a UK-based biotechnology research company, partnered with EKF Diagnostics to become the UK distributor for PrimeStore Molecular Transport Medium (MTM). This partnership allows VH Bio to distribute PrimeStore MTM, which is designed for the safe collection and transport of biological samples, particularly for molecular diagnostics. PrimeStore MTM stabilizes nucleic acids in samples, making it essential for applications like PCR testing. EKF Diagnostics is a UK-based company specializing in the development, manufacturing, and distribution of innovative medical technologies in diagnostics and biotechnology.

Major companies operating in the transport media market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Hardy Diagnostics, HiMedia Laboratories Pvt. Ltd., Titan Biotech Ltd., Merck KGaA, Lonza Group AG, BioLife Solutions Inc., Copan Diagnostics Inc., Eiken Chemical Co.Ltd., Puritan Medical Products, Trinity Biotech plc, Sarstedt AG & Co., Neogen Corporation, Medical Wire & Equipment Co. Ltd., Creative Diagnostics, MedSchenker, Alifax S.r.l., Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., Sisco Research Laboratories Pvt. Ltd., Falcon Laboratories Inc., LAB M Holdings Ltd., Nissui Pharmaceutical Co. Ltd., Spectrum Chemical Manufacturing Corp., TCS Biosciences Ltd., BioMerieux SA, Biomed Diagnostics Inc.

North America was the largest region in the transport media market in 2024. The regions covered in the transport media market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the transport media market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Transport media play a crucial role in safeguarding specimens and minimizing bacterial growth from the point of collection to their arrival at the laboratory for processing. These specialized media are designed to preserve specimens and inhibit the proliferation of bacteria throughout the entire sample processing journey.

Within the category of transport media, key products include viral transport media, universal transport media, molecular transport media, and others. These products serve the purpose of preserving specimens related to both viral and non-viral diseases. Viral transport media specifically refers to the solution used for preserving and transporting clinical specimens, such as respiratory secretions, intended for laboratory testing. Widely applied in various contexts, including diagnosis and preclinical testing, these transport media find utility among end users such as hospitals, clinics, microbiology laboratories, and other healthcare facilities.

The transport media market research report is one of a series of new reports that provides transport media market statistics, including transport media industry global market size, regional shares, competitors with a transport media market share, detailed transport media market segments, market trends and opportunities, and any further data you may need to thrive in the transport media industry. This transport media market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transport media market includes revenue earned by providing swab media, specimen transport media, and nonenveloped RNA viruses transport media. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.